will see their genotype report below and the solutions in the Lifehacks section.
The key to both longevity and cancer prevention may lie at the tail end of each strand of your DNA. Telomeres are found on the ends of all of your chromosomes and are composed of repeated nucleotides (the A, G, and T’s). They cap off the ends of the chromosomes, protecting the nuclear DNA during replication before cell division.[ref]
Lengthened telomeres can lead to cellular regeneration, but this is a double-edged sword that cancer cells can use to their advantage. This article covers the science of telomeres, how they can be lengthened, and how variants in telomere-related genes impact longevity and cancer risk.
Each time a cell divides, it makes a copy of the nuclear DNA, and a little bit of the telomere is lost. When DNA replicates, it gets copied all the way down the long strand, but… it can’t replicate the very end part of the chromosome, where the telomere is located.
Each time DNA is copied, the telomere at the end of the chromosome gets shorter.
Eventually, the telomere shortens so much that it signals the cell to stop dividing. Not enough of the remaining telomere can protect the end of the chromosome from being lost when replicating.
As a result, signals are produced to cause the cell to either be destroyed through apoptosis or to remain senescent. Cellular senescence is a state where a cell can no longer dive and function properly. Normally, the senescent cell will give off inflammatory signals, prompting the body’s immune system to come in and clear out the cell. But as we age, too many senescent cells can overwhelm the body’s ability to get rid of them, which increases the overall inflammatory burden.
Cells are replicating and dividing all the time in the body. You are constantly losing skin cells and making new ones. The cells in the intestines are constantly dividing and turning over every three to five days. Other cells, like neurons in the brain, generally do not replicate very often (if at all).[ref][ref]
Adult stem cells, also called somatic stem cells, are cells that can become different types of cells.
Take, for example, the cells in the intestines that are dividing all the time… Eventually, the cells reach the point at which they can no longer divide because the telomeres are too short. This initiates apoptosis (cell death). Now the stem cells can create new cells that line the crypts in the intestines.[ref]
The enzyme called telomerase reverse transcriptase is responsible for replenishing telomeres. This process of telomere lengthening happens regularly in stem cells (to some extent) — and in cancer cells (a lot!). Telomerase is also active in lymphocytes (immune system cells) and keratinocytes (skin cells).[ref]
Telomerase adds back nucleotide repeats to the end of the chromosomes, thus replenishing and lengthening telomeres.[ref]
In the body’s regular cells, telomerase is turned off. This causes the replicating cells to have a biological time clock in them — replicate enough times, and then cell death occurs. Most cells divide about 50 times, which is known as the Hayflick limit.[ref]
As we age, telomerase activity in stem cells decreases. Eventually, the stem cells may become senescent.[ref]
Is it possible to increase the length of telomeres by activating telomerase in regular cells? Studies show that there are things we can do to increase the length of our telomeres – more on that in the Lifehacks section.
Cellular senescence is a state where the cell is no longer dividing but doesn’t go through apoptosis. Instead, the cell stays active and actively produces cytokines. Senescence can be a good thing when it comes to tumor cells. It helps to stop the growth and triggers signals so the immune system can remove them.
On the other hand, cellular senescence is also thought to be one reason for the problems seen in aging. Senescent cells give off inflammatory cytokines, increasing inflammation in tissues or organs. These signals given off by the senescent cells can also transform neighboring cells.[ref]
Cardiovascular disease has an association with shorter telomere length, and genetic variants that cause shorter telomeres increase the risk of cardiovascular disease.[ref] Repeatedly, many studies have shown an increase in heart attack and stroke risk.[ref]
More specifically, short telomeres and increased atherosclerosis in the carotid arteries are connected. Definitely not a good thing.[ref]
Type 2 diabetes is also associated with shorter telomere length. For each standard deviation decrease in telomere length, the risk of diabetes increases by 37%.[ref]
Bipolar disorder shows associations with significantly shorter telomere lengths.[ref]
PTSD from sexual assault or childhood trauma (but not combat) is associated with shorter telomere length.[ref]
Various different cancers have associations with shortened telomeres, possibly because shortened telomeres could cause more DNA instability.[ref]
There are mouse studies showing that increasing telomerase reduces the effects of aging. Human cell studies show that modifying the mRNA for telomerase can increase telomere length.[ref][ref]
A really cool study showed that turning off the telomerase gene (TERT) caused rapid aging in mice, and then turning back on the gene reversed the aging.[ref] Another mouse study, done in mice bred to be cancer-resistant, found that increasing telomerase extended lifespan by 43%.[ref]
Upregulating telomerase levels in the skin cells of mice resulted in faster wound healing, but the mice were also much more susceptible to skin cancer.[ref] Timing may matter on this, though, since old mice that had telomerase reactivation using gene therapy increased longevity (24%) and didn’t have an increase in cancer.[ref]
There are still a lot of questions to be answered in this field.
On the one hand, shorter telomeres may decrease immune function, increasing the risk of several types of cancer.[ref]
On the other hand, telomerase is greatly elevated in cancer, leading to the immortality of some cancer cells. Plus, genetically longer telomere length is associated with an increased risk of lung cancer in non-smokers (Asian women) and with an increased risk of kidney cancer.[ref][ref]
Telomerase is reactivated (turned on) in 90% of cancer cells, leading to the hallmark of limitless growth in the cells.[ref] Mutations in the TERT (telomerase enzyme) gene are commonly found in cancer cells. These are not inherited mutations but mutations that happen in cells that become cancerous.[ref]
In general, things that increase cell growth can also increase cancer cell growth. So always keep in mind that telomerase is also involved in cancer growth. When reading about ways to increase telomerase, there could be a balance between decreasing the effects of aging and promoting cancer.[ref] There is still a lot of research to be done on this topic, so a little caution is justified when trying to increase telomerase.
Telomerase has also been shown to be active outside of its job of increasing telomere length. Within the mitochondria, telomerase has been shown to regulate reactive oxygen species. In heart disease, telomerase activity in the mitochondria is protective against atherosclerosis.[ref]
Telomerase has also been shown to regulate gene expression, and this is an ongoing field of research.[ref]
Telomeres, in most studies, are measured in leukocytes, which are a type of white blood cell in the immune system.
There are several telomere testing companies now in the US and Europe. I haven’t used any of them, so I can’t comment on how valid the results are (or aren’t).
Testing the length of telomeres for determining biological age is still fairly new, though. Here is an interesting article that brings up several critical points about the flaws in current direct-to-consumer telomere testing companies: Telomere Testing: Science or Snake Oil
Natural inhibitors of telomerase are things we often use for health and cancer prevention. Here is a partial list[ref]:
Ait-Aissa, Karima, et al. “Friend or Foe? Telomerase as a Pharmacological Target in Cancer and Cardiovascular Disease.” Pharmacological Research, vol. 111, Sept. 2016, pp. 422–33. PubMed Central, https://doi.org/10.1016/j.phrs.2016.07.003.
Astuti, Yuliana, et al. “Cigarette Smoking and Telomere Length: A Systematic Review of 84 Studies and Meta-Analysis.” Environmental Research, vol. 158, Oct. 2017, pp. 480–89. PubMed, https://doi.org/10.1016/j.envres.2017.06.038.
Batista, Rui, et al. “The Prognostic Impact of TERT Promoter Mutations in Glioblastomas Is Modified by the Rs2853669 Single Nucleotide Polymorphism.” International Journal of Cancer, vol. 139, no. 2, July 2016, pp. 414–23. PubMed, https://doi.org/10.1002/ijc.30057.
Benetos, Athanase, et al. “Short Telomeres Are Associated with Increased Carotid Atherosclerosis in Hypertensive Subjects.” Hypertension (Dallas, Tex.: 1979), vol. 43, no. 2, Feb. 2004, pp. 182–85. PubMed, https://doi.org/10.1161/01.HYP.0000113081.42868.f4.
Bernardes de Jesus, Bruno, et al. “Telomerase Gene Therapy in Adult and Old Mice Delays Aging and Increases Longevity without Increasing Cancer.” EMBO Molecular Medicine, vol. 4, no. 8, Aug. 2012, pp. 691–704. PubMed Central, https://doi.org/10.1002/emmm.201200245.
Bojesen, Stig E., et al. “Multiple Independent Variants at the TERT Locus Are Associated with Telomere Length and Risks of Breast and Ovarian Cancer.” Nature Genetics, vol. 45, no. 4, Apr. 2013, pp. 371-384e2. PubMed Central, https://doi.org/10.1038/ng.2566.
Borghini, Andrea, et al. “Chronic and Acute Effects of Endurance Training on Telomere Length.” Mutagenesis, vol. 30, no. 5, Sept. 2015, pp. 711–16. PubMed, https://doi.org/10.1093/mutage/gev038.
Bressler, Jan, et al. “Sequence Variation in Telomerase Reverse Transcriptase (TERT) as a Determinant of Risk of Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study.” BMC Medical Genetics, vol. 16, July 2015, p. 52. PubMed, https://doi.org/10.1186/s12881-015-0194-x.
Checking Your Browser – reCAPTCHA. https://pmc.ncbi.nlm.nih.gov/articles/PMC3370421/. Accessed 30 June 2026.
Codd, Veryan, et al. “Identification of Seven Loci Affecting Mean Telomere Length and Their Association with Disease.” Nature Genetics, vol. 45, no. 4, Apr. 2013, pp. 422–27. www.nature.com, https://doi.org/10.1038/ng.2528.
———. “Identification of Seven Loci Affecting Mean Telomere Length and Their Association with Disease.” Nature Genetics, vol. 45, no. 4, Apr. 2013, pp. 422-427e2. PubMed Central, https://doi.org/10.1038/ng.2528.
Costa, Danielle de Souza, et al. “Telomere Length Is Highly Inherited and Associated with Hyperactivity-Impulsivity in Children with Attention Deficit/Hyperactivity Disorder.” Frontiers in Molecular Neuroscience, vol. 8, July 2015, p. 28. PubMed Central, https://doi.org/10.3389/fnmol.2015.00028.
Du, Mengmeng, Jennifer Prescott, Marilyn C. Cornelis, et al. “Genetic Predisposition to Higher Body Mass Index or Type 2 Diabetes and Leukocyte Telomere Length in the Nurses’ Health Study.” PLoS ONE, vol. 8, no. 2, Feb. 2013, p. e52240. PubMed Central, https://doi.org/10.1371/journal.pone.0052240.
Du, Mengmeng, Jennifer Prescott, Peter Kraft, et al. “Physical Activity, Sedentary Behavior, and Leukocyte Telomere Length in Women.” American Journal of Epidemiology, vol. 175, no. 5, Mar. 2012, pp. 414–22. PubMed, https://doi.org/10.1093/aje/kwr330.
Eisenberg, Dan T. A. “An Evolutionary Review of Human Telomere Biology: The Thrifty Telomere Hypothesis and Notes on Potential Adaptive Paternal Effects.” American Journal of Human Biology: The Official Journal of the Human Biology Council, vol. 23, no. 2, 2011, pp. 149–67. PubMed, https://doi.org/10.1002/ajhb.21127.
Flores, Ignacio, et al. “The Longest Telomeres: A General Signature of Adult Stem Cell Compartments.” Genes & Development, vol. 22, no. 5, Mar. 2008, pp. 654–67. PubMed Central, https://doi.org/10.1101/gad.451008.
Ganesan, Kumar, and Baojun Xu. “Telomerase Inhibitors from Natural Products and Their Anticancer Potential.” International Journal of Molecular Sciences, vol. 19, no. 1, Dec. 2017, p. 13. PubMed Central, https://doi.org/10.3390/ijms19010013.
Grieshober, Laurie, et al. “A Cross-Sectional Analysis of Telomere Length and Sleep in the Women’s Health Initiative.” American Journal of Epidemiology, vol. 188, no. 9, Sept. 2019, pp. 1616–26. PubMed, https://doi.org/10.1093/aje/kwz134.
Han, Hongmei, et al. “Association of TERT Polymorphisms and Risk of Coronary Heart Disease in a Chinese Han Population.” Oncotarget, vol. 8, no. 40, June 2017, pp. 67519–25. PubMed Central, https://doi.org/10.18632/oncotarget.18727.
Harley, Calvin B., Weimin Liu, Maria Blasco, et al. “A Natural Product Telomerase Activator As Part of a Health Maintenance Program.” Rejuvenation Research, vol. 14, no. 1, Feb. 2011, pp. 45–56. PubMed Central, https://doi.org/10.1089/rej.2010.1085.
Harley, Calvin B., Weimin Liu, Peter L. Flom, et al. “A Natural Product Telomerase Activator as Part of a Health Maintenance Program: Metabolic and Cardiovascular Response.” Rejuvenation Research, vol. 16, no. 5, Oct. 2013, pp. 386–95. PubMed, https://doi.org/10.1089/rej.2013.1430.
Herz, Corinna, et al. “Low-Dose Levels of Bisphenol A Inhibit Telomerase via ER/GPR30-ERK Signalling, Impair DNA Integrity and Reduce Cell Proliferation in Primary PBMC.” Scientific Reports, vol. 7, Nov. 2017, p. 16631. PubMed Central, https://doi.org/10.1038/s41598-017-15978-2.
Huang, Peixin, et al. “A Critical Role of Nicotinamide Phosphoribosyltransferase in Human Telomerase Reverse Transcriptase Induction by Resveratrol in Aortic Smooth Muscle Cells.” Oncotarget, vol. 6, no. 13, Mar. 2015, pp. 10812–24. PubMed Central, https://doi.org/10.18632/oncotarget.3580.
Khavinson, V. Kh, I. E. Bondarev, and A. A. Butyugov. “Epithalon Peptide Induces Telomerase Activity and Telomere Elongation in Human Somatic Cells.” Bulletin of Experimental Biology and Medicine, vol. 135, no. 6, June 2003, pp. 590–92. PubMed, https://doi.org/10.1023/a:1025493705728.
———. “Peptide Promotes Overcoming of the Division Limit in Human Somatic Cell.” Bulletin of Experimental Biology and Medicine, vol. 137, no. 5, May 2004, pp. 503–06. PubMed, https://doi.org/10.1023/b:bebm.0000038164.49947.8c.
Kiecolt-Glaser, Janice K., et al. “Omega-3 Fatty Acids, Oxidative Stress, and Leukocyte Telomere Length: A Randomized Controlled Trial.” Brain, Behavior, and Immunity, vol. 28, Feb. 2013, pp. 16–24. PubMed Central, https://doi.org/10.1016/j.bbi.2012.09.004.
Kote-Jarai, Zsofia, et al. “Fine-Mapping Identifies Multiple Prostate Cancer Risk Loci at 5p15, One of Which Associates with TERT Expression.” Human Molecular Genetics, vol. 22, no. 12, June 2013, pp. 2520–28. PubMed, https://doi.org/10.1093/hmg/ddt086.
Lee, Alice W., et al. “A Splicing Variant of TERT Identified by GWAS Interacts with Menopausal Estrogen Therapy in Risk of Ovarian Cancer.” International Journal of Cancer, vol. 139, no. 12, Dec. 2016, pp. 2646–54. PubMed Central, https://doi.org/10.1002/ijc.30274.
Li, Xuemei, et al. “The Association between Post-Traumatic Stress Disorder and Shorter Telomere Length: A Systematic Review and Meta-Analysis.” Journal of Affective Disorders, vol. 218, Aug. 2017, pp. 322–26. PubMed, https://doi.org/10.1016/j.jad.2017.03.048.
Liu, H. F., et al. “[Association between sleep and leukocyte telomere length in middle-aged and older adults].” Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi, vol. 38, no. 7, July 2017, pp. 889–92. PubMed, https://doi.org/10.3760/cma.j.issn.0254-6450.2017.07.008.
Liu, Ping, et al. “Anti-Aging Implications of Astragalus Membranaceus (Huangqi): A Well-Known Chinese Tonic.” Aging and Disease, vol. 8, no. 6, Dec. 2017, pp. 868–86. PubMed Central, https://doi.org/10.14336/AD.2017.0816.
Ludlow, Andrew T., et al. “Relationship between Physical Activity Level, Telomere Length, and Telomerase Activity.” Medicine and Science in Sports and Exercise, vol. 40, no. 10, Oct. 2008, pp. 1764–71. PubMed, https://doi.org/10.1249/MSS.0b013e31817c92aa.
Machiela, Mitchell J., et al. “Genetic Variants Related to Longer Telomere Length Are Associated with Increased Risk of Renal Cell Carcinoma.” European Urology, vol. 72, no. 5, Nov. 2017, pp. 747–54. PubMed Central, https://doi.org/10.1016/j.eururo.2017.07.015.
Mathur, Shishir, et al. “Telomere Length and Cardiorespiratory Fitness in Marathon Runners.” Journal of Investigative Medicine: The Official Publication of the American Federation for Clinical Research, vol. 61, no. 3, Mar. 2013, pp. 613–15. PubMed, https://doi.org/10.2310/JIM.0b013e3182814cc2.
Park, Jung-ha, et al. “Promotion of Intestinal Epithelial Cell Turnover by Commensal Bacteria: Role of Short-Chain Fatty Acids.” PLoS ONE, vol. 11, no. 5, May 2016, p. e0156334. PubMed Central, https://doi.org/10.1371/journal.pone.0156334.
Peng, Zesheng, et al. “Telomerase Reverse Transcriptase (TERT) Rs2736100 Polymorphism Contributes to Increased Risk of Glioma: Evidence from a Meta-Analysis.” International Journal of Clinical and Experimental Medicine, vol. 8, no. 1, 2015, pp. 422–30.
Prescott, Jennifer, et al. “Telomere Length and Genetic Analyses in Population-Based Studies of Endometrial Cancer Risk.” Cancer, vol. 116, no. 18, Sept. 2010, pp. 4275–82. PubMed, https://doi.org/10.1002/cncr.25328.
Rachakonda, P. Sivaramakrishna, et al. “TERT Promoter Mutations in Bladder Cancer Affect Patient Survival and Disease Recurrence through Modification by a Common Polymorphism.” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 43, Oct. 2013, pp. 17426–31. PubMed Central, https://doi.org/10.1073/pnas.1310522110.
Rafnar, Thorunn, et al. “Variants Associating with Uterine Leiomyoma Highlight Genetic Background Shared by Various Cancers and Hormone-Related Traits.” Nature Communications, vol. 9, Sept. 2018, p. 3636. PubMed Central, https://doi.org/10.1038/s41467-018-05428-6.
Rs2242652 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs2242652. Accessed 30 June 2026.
Rs2736100 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs2736100. Accessed 30 June 2026.
Rs2736108 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs2736108. Accessed 30 June 2026.
Rs2736122 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs2736122. Accessed 30 June 2026.
Rs2853669 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs2853669. Accessed 30 June 2026.
Rs7675998 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs7675998. Accessed 30 June 2026.
Rs9420907 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs9420907. Accessed 30 June 2026.
Rs10069690 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs10069690. Accessed 30 June 2026.
Rs10936599 RefSNP Report – dbSNP – NCBI. https://www.ncbi.nlm.nih.gov/snp/rs10936599. Accessed 30 June 2026.
Shin, Yun-A. “How Does Obesity and Physical Activity Affect Aging?: Focused on Telomere as a Biomarker of Aging.” Journal of Obesity & Metabolic Syndrome, vol. 28, no. 2, June 2019, pp. 92–104. PubMed, https://doi.org/10.7570/jomes.2019.28.2.92.
Son, Jin H., et al. “Neuronal Autophagy and Neurodegenerative Diseases.” Experimental & Molecular Medicine, vol. 44, no. 2, Feb. 2012, pp. 89–98. PubMed Central, https://doi.org/10.3858/emm.2012.44.2.031.
Stenbäck, Ville, et al. “Association of Physical Activity With Telomere Length Among Elderly Adults – The Oulu Cohort 1945.” Frontiers in Physiology, vol. 10, 2019, p. 444. PubMed, https://doi.org/10.3389/fphys.2019.00444.
Teo, Jing Xian, et al. “Digital Phenotyping by Consumer Wearables Identifies Sleep-Associated Markers of Cardiovascular Disease Risk and Biological Aging.” Communications Biology, vol. 2, no. 1, Oct. 2019, p. 361. www.nature.com, https://doi.org/10.1038/s42003-019-0605-1.
Tomás-Loba, Antonia, et al. “Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice.” Cell, vol. 135, no. 4, Nov. 2008, pp. 609–22. PubMed, https://doi.org/10.1016/j.cell.2008.09.034.
Tran, Hoai Thi Thu, et al. “Short-Term Dietary Intervention with Cooked but Not Raw Brassica Leafy Vegetables Increases Telomerase Activity in CD8+ Lymphocytes in a Randomized Human Trial.” Nutrients, vol. 11, no. 4, Apr. 2019, p. 786. PubMed, https://doi.org/10.3390/nu11040786.
Turnbull, Clare, et al. “Variants near DMRT1, TERT and ATF7IP Are Associated with Testicular Germ Cell Cancer.” Nature Genetics, vol. 42, no. 7, July 2010, pp. 604–07. PubMed Central, https://doi.org/10.1038/ng.607.
Wang, Xu, et al. “Combining Telomerase Reverse Transcriptase Genetic Variant Rs2736100 with Epidemiologic Factors in the Prediction of Lung Cancer Susceptibility.” Journal of Cancer, vol. 7, no. 7, Apr. 2016, pp. 846–53. PubMed Central, https://doi.org/10.7150/jca.13437.
Wu, Dapeng, et al. “Genetic Variations in TERC and TERT Genes Are Associated with Renal Cell Carcinoma Risk in a Chinese Han Population.” Oncotarget, vol. 8, no. 44, Aug. 2017, pp. 76832–42. PubMed Central, https://doi.org/10.18632/oncotarget.20163.
Wynchank, Dora, et al. “Delayed Sleep-Onset and Biological Age: Late Sleep-Onset Is Associated with Shorter Telomere Length.” Sleep, vol. 42, no. 10, Oct. 2019, p. zsz139. PubMed, https://doi.org/10.1093/sleep/zsz139.
Ye, Gang, et al. “Genetic Variations in TERC and TERT Genes Are Associated with Lung Cancer Risk in a Chinese Han Population.” Oncotarget, vol. 8, no. 66, Dec. 2017, pp. 110145–52. PubMed, https://doi.org/10.18632/oncotarget.22329.
Yu, Yongjie, et al. “Cycloastragenol: An Exciting Novel Candidate for Age-Associated Diseases.” Experimental and Therapeutic Medicine, vol. 16, no. 3, Sept. 2018, pp. 2175–82. PubMed Central, https://doi.org/10.3892/etm.2018.6501.